RenDx Gastroplex Assay
Gastrointestinal infections remain a major cause of morbidity and mortality worldwide and represent a major cause of ward closure, both in Europe and the United States, impacting heavily on healthcare budgets and patient recovery times. The rapid and accurate identification of bacterial pathogens associated with gastroenteritis can aid acute patient management decisions, while minimising cost from presumptive isolation and hospital stay.
The RenDx Gastroplex Bacterial panel will detect target DNA directly from faecal samples using standard extraction methods. Designed for use with the RenDx Multiplex Assay system, the assay will provide a fast, semi-automated test to aid diagnosis of symptomatic patients, offering the potential of improved patient management and reduced care costs.